Published online December 1, 2004
PEDIATRICS Vol. 114 No. 6 December 2004, pp. 1740-1741 (doi:10.1542/peds.2004-1983)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Related articles in Pediatrics
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeskind, P. S.
Right arrow Articles by Stephens, L. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zeskind, P. S.
Right arrow Articles by Stephens, L. E.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Findings From Selective Serotonin Reuptake Inhibitor-Exposed Neonates Should Be Interpreted With Caution: In Reply

Philip Sanford Zeskind, PhD
Laura E. Stephens
Carolinas Medical Center
Charlotte, NC 28232

The first 20% of the full text of this article appears below.

In Reply.—

I am pleased that the letter by Norton et al gives us the opportunity to clarify the significance and limitations of the findings of our study on the association between maternal use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and neonatal neurobehavior. As we described in our article, maternal depression during pregnancy is an important public health concern, with implications not only for the health of the mother but also for the health and development of the infant. Treatment of this condition has focused on mothers using SSRIs, with the assumption that these medications are safe for the developing fetus. Our concern is that this assumption is based on research that indicates that prenatal SSRI exposure has little or no impact on development, because exposed infants are born mostly of full birth weight, at full term, and show few physical anomalies. However, over the past 30 years, significant research literature has . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in Pediatrics:

Early Intervention in Preterm Infants After Discharge From Hospital: In Reply
Heidelise Als
Pediatrics 2004 114: 1739. [Extract] [Full Text]